Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0335 | ||||
| Gene Name | SLC38A8 | ||||
| Protein Name | Putative sodium-coupled neutral amino acid transporter 8 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | FVH2; SLC38A8; Solute carrier family 38 member 8 | ||||
| DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
| Tissue Specificity | Expressed in fetal and adult brain, and spinalcord. In the brain, it is localized in the cell body and axon ofthe majority of neuronal cells and in a subset of glial cells.Found throughout the neuronal retina, with higher expressionlevels in the inner and outer plexiform layers and thephotoreceptor layer. Very weak expression is also present in thekidneys, thymus, and testes. | ||||
| Function | This transporter is putative sodium-dependent amino acid/proton antiporter. | ||||
| Endogenous Substrate(s) | Amino acids; Proton | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
L-glutamic acid
|
Approved | Drug Info | Schizophrenia | 6A20 | [1] |
| References | |||||
| 1 | Structural modeling of a novel SLC38A8 mutation that causes foveal hypoplasia. Mol Genet Genomic Med. 2017 Feb 26;5(3):202-209. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.